Digital Marketing Trends in Breast Cancer
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Digital Marketing Trends in Breast Cancer Report Overview
Between November 2021 and October 2022, Merck & Co’s Keytruda.com achieved the highest traffic among branded breast cancer patient sites in the US. This was followed by Eli Lilly’s Verzenio.com. The highest proportion of traffic to branded sites originated from direct sources, followed by organic sources.
The digital marketing trends in the breast cancer report will help to understand the digital marketing competitive landscape in BC, with a view of leading patient and HCP branded assets across different regions. The report also offers information on what tactics pharma companies are using to drive traffic to their BC branded assets for patients and HCPs, such as DDA and paid SEO.
Major US Patient Branded Websites for Breast Cancer
The major US patient-branded websites for Breast cancer are Keytruda.com, Verzenio.com, Ibrance.com, Piqray.com, Lynparza.com, and Herceptin.com. Merck & Co’s Keytruda.com achieved the highest traffic across breast cancer patient sites in the US from November 2021 to October 2022.
Total Traffic Engagement in Breast Cancer, by the US Patient-Branded Websites
For more insights on total traffic engagement of the US patient branded websites, download a free report sample
Major US HCP Branded Websites for Breast Cancer
The major US HCP-branded websites for Breast cancer are Keytrudahcp.com, Lynparzahcp.com, and Ibrance.pfizerpro.com. Merck & Co’s Keytrudahcp.com had the highest traffic among top breast cancer websites for HCPs in the US between November 2021 and October 2022.
Total Traffic Engagement in Breast Cancer, by the US HCP Branded Websites
For more insights on total traffic engagement of the US HCP branded websites, download a free report sample
US Patient-Branded Websites DDA Spend and Paid SEO for Breast Cancer
Pfizer spent the most on DDA for Ibrance.com between November 2021 and October 2022, followed by Eli Lilly’s Verzenio.com, Keytruda.com, and Lynparza.com. The top publisher of ads across the 12 months was YouTube, followed by Google Display Network, and Direct Buy.
Total DDA Spend for Breast Cancer, by Branded US BC Patient Sites
For more insights on DDA spending of branded US BC patient sites, download a free report sample
US HCP Branded Websites DDA Spend and Paid SEO for Breast Cancer
Merck & Co’s Keytrudahcp.com and AstraZeneca’s Lynparzahcp.com were the only HCP sites where DDA spending was detected. Keytrudahcp.com was supported by the most paid SEO keywords, followed by Lynparzahcp.com.
Total DDA Spend for Breast Cancer, by Branded US BC HCP Sites
For more insights on DDA spending of branded US BC HCP sites, download a free report sample
Top Pharma US Mobile Apps and Social Media Channels Related to BC
The top pharma US social media networks related to BC are LoxoLillyOncInt, Lilly Medical US, Roche, Eli Lilly and Company, Bristol Myers Squibb, and Pfizer Oncology Medical. Between November 2021 and October 2022, the top 20 breast cancer social media posts by interaction from pharma companies were from the Loxo Lilly Oncology International corporate Twitter page, the Lilly Medical US Twitter page, and the Roche Instagram page.
Top Pharma EUCAN Mobile Apps and Social Media Channels Related to BC
Like the US, several pharma companies have developed apps for breast cancer patients in EUCAN countries. For instance, Roche’s Wikiboop – Cancer Du Sein app in France and Novartis’s Aktiv Trotz Brustkrebs app and AstraZeneca/Merck & Co’s BRCAplus app in Germany.
Breast Cancer Digital Marketing Report Overview
Major US Patient-Branded Websites | Keytruda.com, Verzenio.com, Ibrance.com, Piqray.com, Lynparza.com, and Herceptin.com |
Major US HCP Branded Websites | Keytrudahcp.com, Lynparzahcp.com, and Ibrance.pfizerpro.com |
Top Pharma US Social Media Channels | LoxoLillyOncInt, Lilly Medical US, Roche, Eli Lilly and Company, Bristol Myers Squibb, and Pfizer Oncology Medical |
Top Pharma EUCAN Social Media Channels | Roche’s Wikiboop – Cancer Du Sein App , Novartis’s Aktiv Trotz Brustkrebs App, and Astrazeneca/Merck & Co’s Brcaplus App |
Scope
- This report assesses key digital marketing metrics of pharma assets in BC, including branded websites for patients and HCPs, mobile apps, and social media accounts.
- Metrics include website traffic volume, engagement, source, DDA, paid SEO, and social media post interaction.
- Countries include the US, 4EU (Italy, France, Germany, and Spain), the UK, and Canada (EUCAN).
Reasons to Buy
- Understand the digital marketing competitive landscape in BC, to lead patient and HCP branded assets across different regions.
- See what tactics pharma companies are using to drive traffic to their BC branded assets for patients and HCPs, such as DDA and paid SEO.
- Understand what sources of website traffic are generating the most visits to these assets, such as paid SEO, social media, or organic searches.
- Compare top branded assets for patients by how they address and support different patient needs.
- See what pharma social media accounts in BC are the most active and achieving the most engagement.
Novartis
Eli Lilly
AstraZeneca
Genentech
Pfizer
Table of Contents
Frequently asked questions
-
What are the major US patient-branded websites for Breast cancer?
The major US patient-branded websites for Breast cancer are Keytruda.com, Verzenio.com, Ibrance.com, Piqray.com, Lynparza.com, and Herceptin.com.
-
What are the major US HCP branded websites for Breast cancer?
The major US HCP-branded websites for Breast cancer are Keytrudahcp.com, Lynparzahcp.com, and Ibrance.pfizerpro.com.
-
What are the top pharma US social media channels for Breast cancer?
The top pharma US social media networks related to BC are LoxoLillyOncInt, Lilly Medical US, Roche, Eli Lilly and Company, Bristol Myers Squibb, and Pfizer Oncology Medical.
-
What are the top pharma EUCAN social media channels for Breast cancer?
Some of the top pharma EUCAN social media channels for Breast cancer are Roche’s Wikiboop – Cancer Du Sein app in France, Novartis’s Aktiv Trotz Brustkrebs app and AstraZeneca/Merck & Co’s BRCAplus app in Germany.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.